Microbiota Transplantation as a Future Novel Therapeutic Strategy Approach.

Area of Science:

• Reproductive Health
• Microbiome Research
• Infectious Diseases

Background:

• Bacterial vaginosis (BV) is a common global cause of genital discomfort, stemming from vaginal microbial imbalance.
• Current treatments (antibiotics, probiotics) have limitations including resistance, recurrence, and incomplete microbiota restoration.

Purpose of the Study:

• To critically evaluate current BV treatments and explore vaginal microbiome transplantation (VMT) as an alternative.
• To discuss challenges and personalized strategies for VMT in BV management.

Main Methods:

• Review of existing literature on BV treatments, VMT efficacy, and influencing factors.
• Analysis of factors contributing to inter-individual variability in VMT outcomes.

Main Results:

• Standard BV therapies have significant limitations.
• VMT shows potential but exhibits considerable inter-individual variability in success.
• Host genetics, baseline microbiota, immune status, and environment likely influence VMT outcomes.

Conclusions:

• Personalized interventions are crucial for effective BV treatment.
• Emerging precision-based strategies are needed to optimize VMT and improve BV management.
• Further research and clinical trials are essential for advancing BV therapeutics.